News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
815,482 Results
Type
Article (75448)
Company Profile (467)
Press Release (739553)
Multimedia
Podcasts (155)
Webinars (26)
Section
Business (223191)
Career Advice (3035)
Deals (38479)
Drug Delivery (136)
Drug Development (88948)
Employer Resources (191)
FDA (17944)
Job Trends (16479)
News (380617)
Policy (37786)
Tag
Academia (2978)
Academic (1)
Accelerated approval (19)
Adcomms (35)
Allergies (134)
Alliances (55263)
ALS (150)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (271)
Approvals (17986)
Artificial intelligence (488)
Autoimmune disease (113)
Automation (31)
Bankruptcy (394)
Best Places to Work (12367)
BIOSECURE Act (23)
Biosimilars (169)
Biotechnology (297)
Bladder cancer (141)
Brain cancer (53)
Breast cancer (531)
Cancer (4248)
Cardiovascular disease (382)
Career advice (2570)
Career pathing (37)
CAR-T (257)
CDC (57)
Cell therapy (703)
Cervical cancer (33)
Clinical research (74076)
Collaboration (1474)
Company closure (4)
Compensation (990)
Complete response letters (64)
COVID-19 (2961)
CRISPR (88)
C-suite (643)
Cystic fibrosis (143)
Data (5177)
Decentralized trials (2)
Denatured (49)
Depression (119)
Diabetes (470)
Diagnostics (7025)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (47)
Drug discovery (224)
Drug pricing (194)
Drug shortages (34)
Duchenne muscular dystrophy (210)
Earnings (94599)
Editorial (57)
Employer branding (23)
Employer resources (165)
Events (127615)
Executive appointments (999)
FDA (20559)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1314)
Gene editing (187)
Generative AI (37)
Gene therapy (572)
GLP-1 (1048)
Government (5205)
Grass and pollen (8)
Guidances (375)
Healthcare (20473)
HIV (47)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (266)
Immuno-oncology (22)
Indications (61)
Infectious disease (3215)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (102)
Intellectual property (203)
Interviews (560)
IPO (17553)
IRA (56)
Job creations (4507)
Job search strategy (2129)
Kidney cancer (16)
Labor market (81)
Layoffs (635)
Leadership (36)
Legal (9437)
Liver cancer (93)
Longevity (13)
Lung cancer (603)
Lymphoma (295)
Machine learning (32)
Management (64)
Manufacturing (665)
MASH (159)
Medical device (14615)
Medtech (14646)
Mergers & acquisitions (21857)
Metabolic disorders (1226)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (241)
Neuropsychiatric disorders (70)
Neuroscience (2795)
NextGen: Class of 2025 (7309)
Non-profit (5031)
Now hiring (60)
Obesity (591)
Opinion (304)
Ovarian cancer (148)
Pain (173)
Pancreatic cancer (184)
Parkinson's disease (247)
Partnered (30)
Patents (438)
Patient recruitment (350)
Peanut (58)
People (64196)
Pharmaceutical (94)
Pharmacy benefit managers (29)
Phase I (22930)
Phase II (32287)
Phase III (24301)
Pipeline (3211)
Policy (305)
Postmarket research (3259)
Preclinical (10285)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (724)
Real estate (6938)
Recruiting (76)
Regulatory (26948)
Reports (56)
Research institute (2685)
Resumes & cover letters (484)
Rett syndrome (19)
RNA editing (16)
RSV (78)
Schizophrenia (142)
Series A (217)
Series B (163)
Service/supplier (21)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (169)
Sponsored (42)
Startups (4097)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (96)
The Weekly (104)
Vaccines (1063)
Venture capital (70)
Weight loss (411)
Women's health (63)
Worklife (21)
Date
Today (174)
Last 7 days (757)
Last 30 days (3669)
Last 365 days (32545)
2025 (28879)
2024 (37432)
2023 (42274)
2022 (53660)
2021 (58387)
2020 (57172)
2019 (50406)
2018 (38238)
2017 (35981)
2016 (36635)
2015 (42744)
2014 (37292)
2013 (33438)
2012 (35214)
2011 (35440)
2010 (34486)
Location
Africa (1071)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (13)
Asia (47041)
Australia (8092)
California (10154)
Canada (2980)
China (966)
Colorado (423)
Connecticut (452)
Delaware (290)
Europe (108008)
Florida (1487)
Georgia (330)
Hawaii (3)
Idaho (66)
Illinois (801)
India (53)
Indiana (491)
Iowa (19)
Japan (342)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (80)
Maryland (1339)
Massachusetts (7498)
Michigan (306)
Minnesota (590)
Mississippi (4)
Missouri (126)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2794)
New Mexico (32)
New York (2716)
North Carolina (1445)
North Dakota (10)
Northern California (4750)
Ohio (308)
Oklahoma (21)
Oregon (43)
Pennsylvania (2085)
Puerto Rico (20)
Rhode Island (43)
South America (1453)
South Carolina (53)
South Dakota (1)
Southern California (3896)
Tennessee (156)
Texas (1553)
United States (36879)
Utah (303)
Virginia (247)
Washington D.C. (85)
Washington State (836)
West Virginia (4)
Wisconsin (103)
Wyoming (2)
815,482 Results for "huntingdon s disease research group chdi foundation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuraLight and CHDI Foundation Collaborate to Develop Precision Eye Movement Biomarkers for Huntington’s Disease
September 10, 2025
·
2 min read
Press Releases
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 28, 2025
·
4 min read
Business
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Evotec SE has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. CHDI is a privately funded nonprofit biomedical research organisation exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease.
May 28, 2024
·
5 min read
Press Releases
The IMA Group Clinical Research Division Continues Expansion with Acquisition of Chicago Research Center
October 8, 2025
·
3 min read
Press Releases
Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results
September 18, 2025
·
3 min read
Press Releases
Prilenia and Ferrer to Share New Data and Analyses of Pridopidine’s Impact on Huntington’s Disease at the Huntington Study Group (HSG) Congress
October 10, 2025
·
9 min read
Press Releases
Hope Biosciences Research Foundation Opens Enrollment for FDA-Authorized Crohn’s Disease Stem Cell Trial
August 20, 2025
·
2 min read
Press Releases
Lung Cancer Research Foundation Welcomes New Member of Board of Directors
November 11, 2025
·
3 min read
Press Releases
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
October 30, 2025
·
8 min read
Press Releases
iTolerance, Inc. Appoints Sandra Cohen Kalter to Strategic Advisory Group
September 23, 2025
·
5 min read
1 of 81,549
Next
